Pharmacologic inhibition of polo-like kinase 1 enhances paclitaxel-based cell killing in taxol-resistant ovarian cancer cells

Marcus, Charlotte

306 - Poster Session A
Pharmacologic inhibition of polo-like kinase 1 enhances paclitaxel-based cell killing in taxol-resistant ovarian cancer cells

Saturday, March 22, 2014: 5:25 PM

West Exhibit Hall (Tampa Convention Center)

C. S. Marcus¹, B. L. Hood², G. Wang², N. W. Bateman², K. A. Conrads², E. A. Dubil¹, K. M. Darcy², G. L. Maxwell³, C. A. Hamilton¹ and T. P. Conrads²
¹Walter Reed National Military Medical Center, Bethesda, MD, ²Gynecologic Cancer Center of Excellence, Annandale, VA, ³Inova Fairfax Hospital, Falls Church, VA

45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Navigation

306 - Poster Session A
Pharmacologic inhibition of polo-like kinase 1 enhances paclitaxel-based cell killing in taxol-resistant ovarian cancer cells

306 - Poster Session A Pharmacologic inhibition of polo-like kinase 1 enhances paclitaxel-based cell killing in taxol-resistant ovarian cancer cells

306 - Poster Session A
Pharmacologic inhibition of polo-like kinase 1 enhances paclitaxel-based cell killing in taxol-resistant ovarian cancer cells